Finding Clinical Trials Is the Real Barrier for Patients
A structural mismatch keeps eligible patients from discovering existing studies, and the fix is a structural one.
Patients who could benefit from clinical trials often never enroll, not because no relevant study exists, but because they have no reliable way to find one. MedCity News describes this as a structural problem with the way trial information is organized and shared, rather than a gap in medical knowledge or regulatory rules.
The article argues that the missing piece is not more research or more data. What is needed is a structural fix that connects existing trials to the patients who are eligible for them. No new science is required, and no new regulation or data collection is needed to close the discovery gap.
Because there is only one source, there is no conflicting viewpoint to compare. The analysis stands on its own as an argument for redesigning how trial information reaches patients, treating the problem as one of navigation and access rather than medical innovation.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.